PELLECCHIA, Maria Teresa
 Distribuzione geografica
Continente #
AS - Asia 13.963
NA - Nord America 7.586
EU - Europa 3.019
SA - Sud America 817
OC - Oceania 88
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 2
Totale 25.535
Nazione #
HK - Hong Kong 10.994
US - Stati Uniti d'America 7.445
SG - Singapore 1.120
CN - Cina 853
IT - Italia 713
BR - Brasile 684
UA - Ucraina 523
RU - Federazione Russa 522
VN - Vietnam 415
DE - Germania 305
IE - Irlanda 283
KR - Corea 188
SE - Svezia 183
TR - Turchia 173
FI - Finlandia 137
GB - Regno Unito 97
CA - Canada 71
IN - India 63
AU - Australia 48
AR - Argentina 46
AT - Austria 39
EE - Estonia 38
NL - Olanda 38
MX - Messico 37
NZ - Nuova Zelanda 36
CZ - Repubblica Ceca 31
PL - Polonia 26
BD - Bangladesh 24
FR - Francia 24
EC - Ecuador 22
JP - Giappone 22
ES - Italia 15
IQ - Iraq 15
VE - Venezuela 14
IL - Israele 13
CO - Colombia 12
PE - Perù 12
ZA - Sudafrica 12
ID - Indonesia 11
PY - Paraguay 11
JM - Giamaica 10
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
GR - Grecia 6
MA - Marocco 6
SA - Arabia Saudita 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
KE - Kenya 5
NP - Nepal 5
TW - Taiwan 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EG - Egitto 4
ET - Etiopia 4
TN - Tunisia 4
BW - Botswana 3
CY - Cipro 3
DZ - Algeria 3
HN - Honduras 3
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
LU - Lussemburgo 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
BZ - Belize 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MG - Madagascar 2
PT - Portogallo 2
RS - Serbia 2
RW - Ruanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AD - Andorra 1
AO - Angola 1
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CU - Cuba 1
Totale 25.509
Città #
Hong Kong 10.984
Ann Arbor 1.422
Chandler 730
Princeton 707
Wilmington 661
Jacksonville 658
Dallas 495
Singapore 412
Ashburn 312
Dublin 271
Dong Ket 270
Woodbridge 233
Houston 223
Beijing 178
Nanjing 156
Izmir 153
Moscow 146
Andover 141
Boardman 126
Pellezzano 109
Naples 106
Dearborn 93
Salerno 90
Los Angeles 66
Ho Chi Minh City 61
Norwalk 56
Düsseldorf 55
Munich 55
Fairfield 54
São Paulo 52
Nanchang 49
Hebei 46
Shenyang 45
Changsha 44
Redwood City 41
Tallinn 38
Jiaxing 36
Pune 32
The Dalles 30
Nuremberg 29
Rome 29
Mestre 27
Hanoi 26
New York 25
Montreal 23
San Francisco 23
Belo Horizonte 22
Rio de Janeiro 22
Seoul 22
Brno 21
West Jordan 21
Council Bluffs 20
Amsterdam 19
Brooklyn 19
Santa Clara 19
Warsaw 19
Boston 18
Milan 17
Seattle 17
Tokyo 17
Turku 17
Washington 17
Auckland 16
Brasília 16
Columbus 16
Tianjin 16
Atlanta 14
Porto Alegre 14
San Diego 14
Sydney 14
Casoria 13
Helsinki 13
Lappeenranta 13
Lecce 13
Campinas 12
Ribeirão Preto 12
Brisbane 11
Cambridge 11
Curitiba 11
Fort Worth 11
Guangzhou 11
Guarulhos 11
London 11
Stockholm 11
Vienna 11
Melbourne 10
Pompei 10
Shanghai 10
Chennai 9
Guayaquil 9
Kunming 9
São José dos Campos 9
Wuhan 9
Chicago 8
Jinan 8
Perugia 8
Ankara 7
Carapicuíba 7
Denver 7
Hefei 7
Totale 20.347
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.156
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles 1.011
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 921
Sex Differences in Parkinson’s Disease: From Bench to Bedside 621
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy 575
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 537
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 514
Gender differences in microRNA expression in levodopa-naive PD patients 510
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 473
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 429
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 357
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 328
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 324
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 308
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 303
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 301
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 279
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 275
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 274
A novel phenotype in an Italian family with a rare progranulin mutation 263
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 255
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 234
Long-Range Auditory Functional Connectivity in Hearing Loss and Rehabilitation 218
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 197
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 190
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 183
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 178
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 173
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 171
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 171
Postganglionic sudomotor denervation in patients with multiple system atrophy. 162
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 157
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 152
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 146
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 144
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 141
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 138
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 133
A critique of the second consensus criteria for multiple system atrophy 130
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 129
Brain anatomical substrates of mirror movements in Kallmann syndrome. 127
Increased bilirubin levels in de novo Parkinson's disease 123
The natural history of multiple system atrophy: A prospective European cohort study 123
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 123
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 120
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 117
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 116
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 114
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 110
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 109
Quitting smoking: An early non-motor feature of Parkinson's disease? 109
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 109
Sindromi parkinsoniane 108
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 108
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease. ICGBD 2022 : International Conference on Global Burden of Disease 108
The alpha-synuclein gene in multiple system atrophy 106
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 105
The accuracy of the arginine growth hormone test in parkinsonism. 103
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 100
Gender and non motor fluctuations in Parkinson's disease: A prospective study 100
A genome-wide association study in multiple system atrophy 100
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 98
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 98
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 97
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 97
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 96
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 95
On the relationship between side of onset and cognition in Parkinson disease 94
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 94
The relevance of gender in Parkinson's disease: a review 93
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 93
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 90
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 90
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 90
Early MRI findings in acquired hepatocerebral degeneration. 89
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 89
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 89
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 88
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 87
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms 86
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 86
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 86
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 85
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 85
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 84
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 84
Uric acid relates to dopamine transporter availability in Parkinson's disease. 83
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale. 82
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 81
“Response to Apomorphine in early Parkinson’s disease”. 81
Parkinson’s disease and the spectrum of Lewy body disease 81
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features 81
Mutant COQ2 in multiple-system atrophy. 80
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 80
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 79
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 79
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 79
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 78
The European Multiple System Atrophy-Study Group (EMSA-SG) 78
Totale 18.917
Categoria #
all - tutte 82.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021956 0 0 0 1 154 80 131 14 120 3 131 322
2021/20221.112 5 7 5 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20253.209 147 35 65 158 159 318 418 342 507 303 379 378
2025/202612.688 3.032 5.189 4.284 183 0 0 0 0 0 0 0 0
Totale 26.138